Cathie Wood started to build up the position in Verve Therapeutics in Q2 2021 and continued to invest until Q4 2023. Since then they sold 7.03 Million shares. The investor completely sold their stake between Q1 2024 and Q3 2024.
Cathie Wood, the brilliant mind behind ARK Invest , is known for her unique ability to spot disruptive trends in stocks. Her investment strategies have made ...
Verve Therapeutics is developing a CRISPR-based gene therapy for cardiovascular diseases. Click here for our take on VERN assets and stock prospects.